Showing 121 - 140 results of 206 for search '"leishmaniasis"', query time: 0.07s Refine Results
  1. 121

    A Comparison between the Effects of Glucantime, Topical Trichloroacetic Acid 50% plus Glucantime, and Fractional Carbon Dioxide Laser plus Glucantime on Cutaneous Leishmaniasis Lesions by Fariba Jaffary, Mohammad Ali Nilforoushzadeh, Amirhossein Siadat, Elaheh Haftbaradaran, Nazli Ansari, Elham Ahmadi

    Published 2016-01-01
    “…Background. Cutaneous leishmaniasis is an endemic disease in Iran. Pentavalent antimonial drugs have been the first line of therapy in cutaneous leishmaniasis for many years. …”
    Get full text
    Article
  2. 122

    Application of kDNA Minicircle PCR-RFLP to Characterize Leishmania donovani Clinical Isolates Obtained from Post-Kala-Azar Dermal Leishmaniasis in Eastern Nepal by Ojesh Pokhrel, Keshav Rai, Narayan Raj Bhattarai, Suman Rijal, Arpana Rijal, Basudha Khanal

    Published 2019-01-01
    “…Post-kala-azar dermal leishmaniasis (PKDL) is a skin manifestation of visceral leishmaniasis (VL) which develops after apparent cure in some patients. …”
    Get full text
    Article
  3. 123
  4. 124
  5. 125

    First Comprehensive List of Phlebotomine Sand Fly Species (Diptera: Psychodidae) in a Leishmaniasis Focus (Djelfa, Algeria), Including the First Record of Phlebotomus langeroni Females in Algeria by Fatma Messaoudene, Slimane Boukraa, Said Chaouki Boubidi, Ahlem Guerzou

    Published 2024-09-01
    “… Background: The wide distribution of phlebotomine vectors complicates the leishmaniasis situation in the world, with the risk of spreading from rural to urban areas. …”
    Get full text
    Article
  6. 126
  7. 127
  8. 128
  9. 129

    The leishmaniases in Kenya: A scoping review. by Grace Grifferty, Hugh Shirley, Katherine O'Brien, Jason L Hirsch, Adrienne M Orriols, Kiira Lani Amechi, Joshua Lo, Neeharika Chanda, Sarra El Hamzaoui, Jorja Kahn, Samantha V Yap, Kyleigh E Watson, Christina Curran, Amina Atef AbdelAlim, Neeloy Bose, Alissa Link Cilfone, Richard Wamai

    Published 2023-06-01
    “…Endemic in over 100 countries, the four types of leishmaniasis-visceral leishmaniasis (VL) (known as kala-azar), cutaneous leishmaniasis (CL), mucocutaneous leishmaniasis (MCL), and post-kala-azar dermal leishmaniasis (PKDL)-put 1.6 billion people at risk. …”
    Get full text
    Article
  10. 130

    Sex-Related Differences in Immune Response and Symptomatic Manifestations to Infection with Leishmania Species by Ryan D. Lockard, Mary E. Wilson, Nilda E. Rodríguez

    Published 2019-01-01
    “…Herein, we review the distribution, morbidity, and mortality among male and female leishmaniasis patients. Additionally, we discuss experimental findings and new avenues of research concerning sex-specific responses in cutaneous and visceral leishmaniasis. …”
    Get full text
    Article
  11. 131
  12. 132
  13. 133

    Inflammatory Nasal Swelling due to Leishmania tropica by Hajiba Fellah, Maryam Hakkour, Bouchra Delouane, Asmae Hmamouch, Abdelhakim Bouyahya, Faiza Sebti, Abderrahim Sadak

    Published 2021-01-01
    “…Since its discovery in the 19th century, cutaneous leishmaniasis has been a major public health problem, especially with the appearance of more and more unusual cases of cutaneous lesions due to this parasite. …”
    Get full text
    Article
  14. 134

    Developments in Diagnosis and Antileishmanial Drugs by Prachi Bhargava, Rajni Singh

    Published 2012-01-01
    “…Leishmaniasis is a diverse group of clinical syndromes caused by protozoan parasites of the genus Leishmania. …”
    Get full text
    Article
  15. 135

    Strategies to Overcome Antileishmanial Drugs Unresponsiveness by Shyam Sundar, Anup Singh, Om Prakash Singh

    Published 2014-01-01
    “…In the absence of effective vector control measures and vaccines against leishmaniasis, effective chemotherapy remains the mainstay of treatment. …”
    Get full text
    Article
  16. 136

    Synthesis and evaluation of nitrochromene derivatives as potential antileishmanial therapeutics through biological and computational studies by Niloofar Javid, Ali Asadipour, Ehsan Salarkia, Mohammad Amin Langarizadeh, Fatemeh Sharifi, Mohammad Mahdavi, Bagher Amirheidari, Aida Iraji, Hojjat Rezaiezadeh, Gholamreza Hassanpour, Yaghoub Pourshojaei

    Published 2025-01-01
    “…Abstract Leishmaniasis is a parasitic disease caused by protozoan organisms belonging to the Leishmania genus, affecting many individuals worldwide, with the burden surpassing one million cases. …”
    Get full text
    Article
  17. 137

    Immunoinformatic approach to the design of a novel multi-epitope vaccine against Leishmania major fused to human IgG-Fc by Mahmood Fadaie, Zabihollah Shahmoradi, Hossein Khanahmad

    Published 2024-12-01
    “…Background and purpose: Cutaneous leishmaniasis poses significant health and socioeconomic challenges, making vaccine development a top priority, especially in endemic regions. …”
    Get full text
    Article
  18. 138
  19. 139

    Clinical, histopathological and parasitological follow-up of dogs naturally infected by Leishmania infantum before and after miltefosine treatment and associated therapies. by Amábilli de Souza Rosar, Carolina Leite Martins, Álvaro Menin, Carolina Reck, Edmundo Carlos Grisard, Glauber Wagner, Mário Steindel, Patricia Hermes Stoco, Patricia Flavia Quaresma

    Published 2025-01-01
    “…As an alternative to euthanizing dogs, miltefosine has been used to treat canine visceral leishmaniasis since 2016. In this study, we have assessed the efficacy of miltefosine for treating canine visceral leishmaniasis in a new endemic area through follow-up of naturally infected dogs was evaluated. …”
    Get full text
    Article
  20. 140

    A novel strain of Leishmania braziliensis harbors not a toti- but a bunyavirus. by Alexei Yu Kostygov, Danyil Grybchuk, Senne Heeren, Evgeny S Gerasimov, Donnamae Klocek, Aditya Reddy, Jovana Sádlová, Lenka Pacáková, Alain Kohl, František Stejskal, Petr Volf, Jean-Claude Dujardin, Vyacheslav Yurchenko

    Published 2024-12-01
    “…Leishmania is a genus of the family Trypanosomatidae that unites obligatory parasitic flagellates causing a variety of vector-borne diseases collectively called leishmaniasis. The symptoms range from relatively innocuous skin lesions to complete failures of visceral organs. …”
    Get full text
    Article